Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis | Journal of Neurology, Neurosurgery & Psychiatry |
| 18 | 2022 |
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis | JAMA Neurology |
| 42 | 2022 |
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients | Journal of Neuroinflammation |
| 37 | 2022 |
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial | 2021 | |||
Myasthenic crisis demanding mechanical ventilation: A multicenter analysis of 250 cases | Neurology |
| 2020 |